These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 24686846)

  • 1. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
    Shi J; Yang XR; Ballew B; Rotunno M; Calista D; Fargnoli MC; Ghiorzo P; Bressac-de Paillerets B; Nagore E; Avril MF; Caporaso NE; McMaster ML; Cullen M; Wang Z; Zhang X; ; ; ; Bruno W; Pastorino L; Queirolo P; Banuls-Roca J; Garcia-Casado Z; Vaysse A; Mohamdi H; Riazalhosseini Y; Foglio M; Jouenne F; Hua X; Hyland PL; Yin J; Vallabhaneni H; Chai W; Minghetti P; Pellegrini C; Ravichandran S; Eggermont A; Lathrop M; Peris K; Scarra GB; Landi G; Savage SA; Sampson JN; He J; Yeager M; Goldin LR; Demenais F; Chanock SJ; Tucker MA; Goldstein AM; Liu Y; Landi MT
    Nat Genet; 2014 May; 46(5):482-6. PubMed ID: 24686846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in POT1 predispose to familial cutaneous malignant melanoma.
    Trigueros-Motos L
    Clin Genet; 2014 Sep; 86(3):217-8. PubMed ID: 24784786
    [No Abstract]   [Full Text] [Related]  

  • 3. POT1 loss-of-function variants predispose to familial melanoma.
    Robles-Espinoza CD; Harland M; Ramsay AJ; Aoude LG; Quesada V; Ding Z; Pooley KA; Pritchard AL; Tiffen JC; Petljak M; Palmer JM; Symmons J; Johansson P; Stark MS; Gartside MG; Snowden H; Montgomery GW; Martin NG; Liu JZ; Choi J; Makowski M; Brown KM; Dunning AM; Keane TM; López-Otín C; Gruis NA; Hayward NK; Bishop DT; Newton-Bishop JA; Adams DJ
    Nat Genet; 2014 May; 46(5):478-481. PubMed ID: 24686849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.
    Wong K; Robles-Espinoza CD; Rodriguez D; Rudat SS; Puig S; Potrony M; Wong CC; Hewinson J; Aguilera P; Puig-Butille JA; Bressac-de Paillerets B; Zattara H; van der Weyden L; Fletcher CDM; Brenn T; Arends MJ; Quesada V; Newton-Bishop JA; Lopez-Otin C; Bishop DT; Harms PW; Johnson TM; Durham AB; Lombard DB; Adams DJ
    JAMA Dermatol; 2019 May; 155(5):604-609. PubMed ID: 30586141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.
    Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S
    Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
    Aoude LG; Pritchard AL; Robles-Espinoza CD; Wadt K; Harland M; Choi J; Gartside M; Quesada V; Johansson P; Palmer JM; Ramsay AJ; Zhang X; Jones K; Symmons J; Holland EA; Schmid H; Bonazzi V; Woods S; Dutton-Regester K; Stark MS; Snowden H; van Doorn R; Montgomery GW; Martin NG; Keane TM; López-Otín C; Gerdes AM; Olsson H; Ingvar C; Borg A; Gruis NA; Trent JM; Jönsson G; Bishop DT; Mann GJ; Newton-Bishop JA; Brown KM; Adams DJ; Hayward NK
    J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25505254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.
    Wilson TL; Hattangady N; Lerario AM; Williams C; Koeppe E; Quinonez S; Osborne J; Cha KB; Else T
    Fam Cancer; 2017 Oct; 16(4):561-566. PubMed ID: 28389767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain.
    Sargen MR; Calista D; Elder DE; Massi D; Chu EY; Potrony M; Pfeiffer RM; Carrera C; Aguilera P; Alos L; Puig S; Elenitsas R; Yang XR; Tucker MA; Landi MT; Goldstein AM
    J Am Acad Dermatol; 2020 Sep; 83(3):860-869. PubMed ID: 32283231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere-lengthening germline variants predispose to a syndromic papillary thyroid cancer subtype.
    DeBoy EA; Nicosia AM; Liyanarachchi S; Iyer SS; Shah MH; Ringel MD; Brock P; Armanios M
    Am J Hum Genet; 2024 Jun; 111(6):1114-1124. PubMed ID: 38688277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based analysis of
    Simonin-Wilmer I; Ossio R; Leddin EM; Harland M; Pooley KA; Martil de la Garza MG; Obolenski S; Hewinson J; Wong CC; Iyer V; Taylor JC; Newton-Bishop JA; Bishop DT; Cisneros GA; Iles MM; Adams DJ; Robles-Espinoza CD
    J Med Genet; 2023 Jul; 60(7):692-696. PubMed ID: 36539277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A
    Abu Shtaya A; Kedar I; Bazak L; Basel-Salmon L; Barhom SF; Naftali M; Eskin-Schwartz M; Birk OS; Polager-Modan S; Keidar N; Reznick Levi G; Levi Z; Yablonski-Peretz T; Mahamid A; Segol O; Matar R; Bareli Y; Azoulay N; Goldberg Y
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.
    Speedy HE; Kinnersley B; Chubb D; Broderick P; Law PJ; Litchfield K; Jayne S; Dyer MJS; Dearden C; Follows GA; Catovsky D; Houlston RS
    Blood; 2016 Nov; 128(19):2319-2326. PubMed ID: 27528712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline
    Andreotti V; Vanni I; Pastorino L; Ghiorzo P; Bruno W
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting Fission Yeast Shelterin Interactions via MICro-MS Links Disruption of Shelterin Bridge to Tumorigenesis.
    Liu J; Yu C; Hu X; Kim JK; Bierma JC; Jun HI; Rychnovsky SD; Huang L; Qiao F
    Cell Rep; 2015 Sep; 12(12):2169-80. PubMed ID: 26365187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia.
    Ramsay AJ; Quesada V; Foronda M; Conde L; Martínez-Trillos A; Villamor N; Rodríguez D; Kwarciak A; Garabaya C; Gallardo M; López-Guerra M; López-Guillermo A; Puente XS; Blasco MA; Campo E; López-Otín C
    Nat Genet; 2013 May; 45(5):526-30. PubMed ID: 23502782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Truncating Germline Mutation of
    He H; Li W; Comiskey DF; Liyanarachchi S; Nieminen TT; Wang Y; DeLap KE; Brock P; de la Chapelle A
    Thyroid; 2020 Feb; 30(2):204-213. PubMed ID: 31928178
    [No Abstract]   [Full Text] [Related]  

  • 17. Constitutional variants in POT1, TERF2IP, and ACD genes in patients with melanoma in the Polish population.
    Malińska K; Deptuła J; Rogoża-Janiszewska E; Górski B; Scott R; Rudnicka H; Kashyap A; Domagała P; Hybiak J; Masojć B; Cybulski C; Kram A; Boer M; Kiedrowicz M; Lubiński J; Dębniak T
    Eur J Cancer Prev; 2020 Nov; 29(6):511-519. PubMed ID: 32976206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The enigma of excessively long telomeres in cancer: lessons learned from rare human POT1 variants.
    Gong Y; Stock AJ; Liu Y
    Curr Opin Genet Dev; 2020 Feb; 60():48-55. PubMed ID: 32155570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. POT1 tumour predisposition: a broader spectrum of associated malignancies and proposal for additional screening program.
    Baptista Freitas M; Desmyter L; Badoer C; Smits G; Vandernoot I; T Kint de Roodenbeke D
    Eur J Hum Genet; 2024 Aug; 32(8):980-986. PubMed ID: 38839987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Germline TERT promoter mutations are rare in familial melanoma.
    Harland M; Petljak M; Robles-Espinoza CD; Ding Z; Gruis NA; van Doorn R; Pooley KA; Dunning AM; Aoude LG; Wadt KA; Gerdes AM; Brown KM; Hayward NK; Newton-Bishop JA; Adams DJ; Bishop DT
    Fam Cancer; 2016 Jan; 15(1):139-44. PubMed ID: 26433962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.